Literature DB >> 11741205

Kinetic modeling of plasmid DNA degradation in rat plasma.

B E Houk1, G Hochhaus, J A Hughes.   

Abstract

A major obstacle in gene delivery is the transport of intact plasmid DNA (pDNA) to target sites. We sought to investigate the kinetic processes underlying the degradation of pDNA in a rat plasma model, as this is one of the main components responsible for the clearance of pDNA after intravenous administration. We further sought to construct a complete kinetic model to describe the degradation of all three topoforms (supercoiled, open circular, and linear) of pDNA in a rat plasma model. Supercoiled pDNA was incubated in isolated rat plasma at 37 degrees C in vitro. At various time points, the plasma was assayed by electrophoresis for the amounts of supercoiled, open circular, and full-length linear pDNA remaining. The calculated amounts remaining were fit to linear differential equations describing this process. In this model, pDNA degradation is considered to be a unidirectional process, with supercoiled degrading to open circular and then to the linear topoform. The calculated kinetic parameters suggested that supercoiled pDNA degrades in rat plasma with a half-life of 1.2 minutes, open circular pDNA degrades with a half-life of 21 minutes, and linear pDNA degrades with a half-life of 11 minutes. Complexation of pDNA with liposomes resulted in a portion of the supercoiled plasmid remaining detectable through 5.5 hours.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11741205      PMCID: PMC2761123          DOI: 10.1208/ps010309

Source DB:  PubMed          Journal:  AAPS PharmSci        ISSN: 1522-1059


  7 in total

1.  Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA.

Authors:  A R Thierry; P Rabinovich; B Peng; L C Mahan; J L Bryant; R C Gallo
Journal:  Gene Ther       Date:  1997-03       Impact factor: 5.250

2.  Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach.

Authors:  G Osaka; K Carey; A Cuthbertson; P Godowski; T Patapoff; A Ryan; T Gadek; J Mordenti
Journal:  J Pharm Sci       Date:  1996-06       Impact factor: 3.534

3.  The clearance and localization of nucleic acids by New Zealand and normal mice.

Authors:  T M Chused; A D Steinberg; N Talal
Journal:  Clin Exp Immunol       Date:  1972-12       Impact factor: 4.330

4.  Initial degradation of deoxyribonucleic acid after injection in mammals.

Authors:  C Gosse; J B Le Pecq; P Defrance; C Paoletti
Journal:  Cancer Res       Date:  1965-07       Impact factor: 12.701

Review 5.  Physiological parameters in laboratory animals and humans.

Authors:  B Davies; T Morris
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

6.  The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake.

Authors:  K Kawabata; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

7.  Biodistribution of radiolabeled lipid-DNA complexes and DNA in mice.

Authors:  R Niven; R Pearlman; T Wedeking; J Mackeigan; P Noker; L Simpson-Herren; J G Smith
Journal:  J Pharm Sci       Date:  1998-11       Impact factor: 3.534

  7 in total
  11 in total

Review 1.  Gene therapy: a pharmacokinetic/pharmacodynamic modelling overview.

Authors:  Zinnia P Parra-Guillén; Gloria González-Aseguinolaza; Pedro Berraondo; Iñaki F Trocóniz
Journal:  Pharm Res       Date:  2010-04-13       Impact factor: 4.200

2.  Cationic versus neutral microbubbles for ultrasound-mediated gene delivery in cancer.

Authors:  David S Wang; Cedric Panje; Marybeth A Pysz; Ramasamy Paulmurugan; Jarrett Rosenberg; Sanjiv S Gambhir; Michel Schneider; Jürgen K Willmann
Journal:  Radiology       Date:  2012-06-21       Impact factor: 11.105

Review 3.  Regulatable gene expression systems for gene therapy applications: progress and future challenges.

Authors:  S Goverdhana; M Puntel; W Xiong; J M Zirger; C Barcia; J F Curtin; E B Soffer; S Mondkar; G D King; J Hu; S A Sciascia; M Candolfi; D S Greengold; P R Lowenstein; M G Castro
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

Review 4.  Regulatable gene expression systems for gene therapy.

Authors:  Nuria Vilaboa; Richard Voellmy
Journal:  Curr Gene Ther       Date:  2006-08       Impact factor: 4.391

5.  Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA.

Authors:  Jørgen de Jonge; Johanna M Leenhouts; Marijke Holtrop; Pieter Schoen; Peter Scherrer; Pieter R Cullis; Jan Wilschut; Anke Huckriede
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

6.  Pharmacokinetics of plasmid DNA in the rat.

Authors:  B E Houk; R Martin; G Hochhaus; J A Hughes
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

7.  Cyclic RGD-targeting of reversibly stabilized DNA nanoparticles enhances cell uptake and transfection in vitro.

Authors:  Qing-Hui Zhou; Ye-Zi You; Chao Wu; Yi Huang; David Oupický
Journal:  J Drug Target       Date:  2009-06       Impact factor: 5.121

8.  Sonoporation increases therapeutic efficacy of inducible and constitutive BMP2/7 in vivo gene delivery.

Authors:  Georg A Feichtinger; Anna T Hofmann; Paul Slezak; Sebastian Schuetzenberger; Martin Kaipel; Ernst Schwartz; Anne Neef; Nikolitsa Nomikou; Thomas Nau; Martijn van Griensven; Anthony P McHale; Heinz Redl
Journal:  Hum Gene Ther Methods       Date:  2013-11-27       Impact factor: 2.396

Review 9.  Gene Therapy for Acute Respiratory Distress Syndrome.

Authors:  Jing Liu; David A Dean
Journal:  Front Physiol       Date:  2022-01-17       Impact factor: 4.566

10.  Targeting of Synthetic Gene Delivery Systems.

Authors:  Andreas G. Schätzlein
Journal:  J Biomed Biotechnol       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.